Transcode Therapeutics Inc (RNAZ) Stock Split History

Transcode Therapeutics Inc has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on May 23, 2023 with the ratio of 1-for-20, meaning that for 20 shares of RNAZ owned pre-split, shareholders then owned 1 share. The most recent stock split took place on January 16, 2024 on a 1-for-40 basis.

These actions have increased RNAZ stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Transcode Therapeutics Inc's total market capitalization.

For more detailed information of Transcode Therapeutics Inc's stock splits, view the table below:

The answer will depend on the decisions of the company's managers and market volatility. Transcode Therapeutics Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when RNAZ stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Transcode Therapeutics Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.